Skip to content

Preimplantation genetic screening (PGS) for aneuploidies in patients with advanced maternal age undergoing in vitro fertilization.

Preimplantation genetic screening (PGS) for aneuploidies in patients with advanced maternal age undergoing in vitro fertilization.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25213
Enrollment
372
Registered
2005-08-15
Start date
2003-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subfertility/infertility in women with advanced maternal age.

Interventions

Patients are allocated at random to one of two treatment arms: IVF/ICSI with PGS (selection of embryos based on normal number of studied chromosomes) or IVF/ICSI without PGS (selection of embryos base

Sponsors

Academic Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 35 and 41 years of age, undergoing IVF (in vitro fertilization) or ICSI (intracytoplasmatic sperm injection).

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate.

Secondary

MeasureTime frame
Time to pregnancy, clinical pregnancy rate, pregnancy outcome, implantation rate.

Contacts

Public ContactSebastiaan Mastenbroek

Academic Medical Center (AMC), Center For Reproductive Medicine, P.O. Box 22660

S.Mastenbroek@amc.uva.nl+31 (0)20 5663090

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)